Aquatic Capital Management LLC Sarepta Therapeutics, Inc. Transaction History

Aquatic Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$93.7 - $141.53 $4.69 Million - $7.09 Million	-50,100 Reduced 84.2%	9,400 $1.22 Million
Q4 2023 Feb 14, 2024	BUY	$67.31 - $124.76 $4 Million - $7.42 Million	59,500 New	59,500 $5.74 Million
Q2 2023 Aug 14, 2023	BUY	$106.4 - $157.19 $1.27 Million - $1.87 Million	11,900 Added 76.77%	27,400 $3.14 Million
Q1 2023 May 15, 2023	BUY	$117.53 - $155.99 $1.48 Million - $1.97 Million	12,600 Added 434.48%	15,500 $2.14 Million
Q4 2022 Feb 14, 2023	BUY	$100.86 - $132.13 $292,494 - $383,177	2,900 New	2,900 $375,000
Q2 2022 Aug 15, 2022	SELL	$62.69 - $88.44 $12,538 - $17,688	-200 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$63.15 - $90.42 $12,630 - $18,084	200 New	200 $16,000

528

85M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $9.79B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Aquatic Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aquatic Capital Management LLC with notifications on news.